(Q50864449)

24 March 2018

title

The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer. (English)

1 reference

24 March 2018

1 reference

2

1 reference

24 March 2018

author name string

Teresa Hemmerle

series ordinal

1

1 reference

24 March 2018

language of work or name

English

0 references

publication date

10 August 2013

1 reference

24 March 2018

International Journal of Cancer

published in

1 reference

24 March 2018

volume

134

1 reference

24 March 2018

issue

2

1 reference

24 March 2018

page(s)

467-477

1 reference

24 March 2018

Cytokines in cancer pathogenesis and cancer therapy

cites work

1 reference

Antibody-cytokine fusion proteins

21 January 2018

1 reference

Selective targeted delivery of TNFalpha to tumor blood vessels.

21 January 2018

1 reference

The immunocytokine F8-IL2 improves the therapeutic performance of sunitinib in a mouse model of renal cell carcinoma

21 January 2018

1 reference

The antibody-based delivery of interleukin-12 to the tumor neovasculature eradicates murine models of cancer in combination with paclitaxel

21 January 2018

1 reference

Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis

21 January 2018

1 reference

Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C.

21 January 2018

1 reference

A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo

21 January 2018

1 reference

A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma.

21 January 2018

1 reference

Combination of temozolomide with immunocytokine F16-IL2 for the treatment of glioblastoma

21 January 2018

1 reference

The targeted delivery of IL17 to the mouse tumor neo-vasculature enhances angiogenesis but does not reduce tumor growth rate

21 January 2018

1 reference

Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation

21 January 2018

1 reference

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis

21 January 2018

1 reference

Inhibition of angiogenesis by interleukin 4.

21 January 2018

1 reference

Murine interleukin-4 displays potent anti-tumor activity in vivo

21 January 2018

1 reference

Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer

21 January 2018

1 reference

Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E5Y92).

21 January 2018

1 reference

Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.

21 January 2018

1 reference

Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin

21 January 2018

1 reference

Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan.

21 January 2018

1 reference

Immunocytokines: a novel class of potent armed antibodies

21 January 2018

1 reference

Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients

21 January 2018

1 reference

Antibody targeted drugs as cancer therapeutics

21 January 2018

1 reference

An engineered antibody-interleukin-12 fusion protein with enhanced tumor vascular targeting properties

21 January 2018

1 reference

An antibody-calmodulin fusion protein reveals a functional dependence between macromolecular isoelectric point and tumor targeting performance.

21 January 2018

1 reference

Interleukin-12 in anti-tumor immunity and immunotherapy.

21 January 2018

1 reference

Crucial role of interleukin-4 in the survival of colon cancer stem cells

21 January 2018

1 reference

Paclitaxel enhances therapeutic efficacy of the F8-IL2 immunocytokine to EDA-fibronectin-positive metastatic human melanoma xenografts

21 January 2018

1 reference

A comparative immunofluorescence analysis of three clinical-stage antibodies in head and neck cancer

21 January 2018

1 reference

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

21 January 2018

1 reference

The Antibody-Mediated Targeted Delivery of Interleukin-15 and GM-CSF to the Tumor Neovasculature Inhibits Tumor Growth and Metastasis

21 January 2018

1 reference

The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model

21 January 2018

1 reference

Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: Two human antibodies investigated in clinical trials in patients with cancer

21 January 2018

1 reference

Three clinical-stage tumor targeting antibodies reveal differential expression of oncofetal fibronectin and tenascin-C isoforms in human lymphoma

21 January 2018

1 reference

Isolated limb perfusion with the tumor-targeting human monoclonal antibody-cytokine fusion protein L19-TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma

21 January 2018

1 reference

Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7

21 January 2018

1 reference

Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy

21 January 2018

1 reference

Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2

21 January 2018

1 reference

The Extra-domain A of Fibronectin Is a Vascular Marker of Solid Tumors and Metastases

21 January 2018

1 reference

Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: Three clinical-grade fully human antibodies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28359

1 reference

24 March 2018

1 reference

24 March 2018